SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1866063
Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal
Song1, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0016
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238
Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria
Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS

DIGEST DIS SCI 2020 10.1007/s10620-020-06591-x
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
Oh1, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH

J VIRAL HEPATITIS 2020 10.1111/jvh.13279
Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients
Kim1, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

J VIRAL HEPATITIS 2020 10.1111/jvh.13306
Long-term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients-Functional cure unlikely
Cho1, JY; Sohn, W; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, CG

TRANSPL P 2020 10.1016/j.transproceed.2020.01.037
Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma
Song1, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS

KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.196
Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance
Kim1, HK; Kang, W; Sinn, DH; Lee, JH; Kim, WS; Kim, SJ

KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.040
Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea
Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

J GASTROEN HEPATOL 2019 10.1111/jgh.14750
Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia
Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

J GASTROINTEST SURG 2019 10.1007/s11605-018-04074-z
Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
Kim1, JM; Kwon, CHD; Joh, JW; Yoo, H; Kim, K; Sinn, DH; Choi, GS; Lee, JH

BMC CANCER 2019 10.1186/s12885-019-5740-z
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Yoon1, JS; Song, BG; Lee, JH; Lee, HY; Kim, SW; Chang, Y; Lee, YB; Cho, EJ; Yu, SJ; Sinn, DH; Kim, YJ; Lee, JH; Yoon, JH

PLoS One 2019 10.1371/journal.pone.0213547
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW

CANCER IMMUNOL IMMUN 2019 10.1007/s00262-018-2247-4
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
Lee1, JH; Lee, JH; Lim, YS; Yeon, JE; Song, TJ; Yu, SJ; Gwak, GY; Kim, KM; Kim, YJ; Lee, JW; Yoon, JH

PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW

EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

LIVER INT 2018 10.1111/liv.13732
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW

SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS

LIVER INT 2018 10.1111/liv.13489
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW